RTW INVESTMENTS, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001493215

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2025 · 74 positions · Total reported value $8.12B · Top-10 concentration 52.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 37.2% · 10 new · 12 cut · 13 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.3% · vs SPY -9.4% · Prev Value $11.71B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.7% · vs SPY -3.9% · Latest Value $9.91B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, RTW INVESTMENTS, LP disclosed 74 equity positions with a combined reported value of $8.12B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 52.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were MDGL ($914.42M), ARGX ($496.74M), RNAM ($495.51M). By sector, the heaviest allocations are Health Care 83.9%, Technology 0.2%. Versus the prior quarter, allocation shifted toward Health Care (+4.3pp) and away from Other (-4.2pp).

Versus the prior quarter, RTW INVESTMENTS, LP opened 10 new positions, trimmed 12 and fully exited 13, a turnover rate of 37.2% of positions. The portfolio's overlap with the prior quarter was 77% of names.

The largest new positions opened in Q3 2025 were COGT ($49.79M), AQST ($34.94M), ABVX ($29.71M).

Of the 13 positions fully exited versus the prior quarter, the largest were VRNA ($288.65M), ABT ($60.39M), SLNO ($35.56M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • COGT COGENT BIOSCIENCES INC · $49.79M
  • AQST AQUESTIVE THERAPEUTICS INC · $34.94M
  • ABVX ABIVAX SA · $29.71M
  • BLTE BELITE BIO INC · $23.12M
  • ALEC ALECTOR INC · $20.69M
  • HTFL HEARTFLOW INC · $16.66M
  • LRMR LARIMAR THERAPEUTICS INC · $10.09M
  • CMPX COMPASS THERAPEUTICS INC · $8.75M

Fully Exited (vs previous quarter)

  • VRNA VERONA PHARMA PLC · prev qtr: $288.65M
  • ABT ABBOTT LABORATORIES · prev qtr: $60.39M
  • SLNO SOLENO THERAPEUTICS INC · prev qtr: $35.56M
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · prev qtr: $34.98M
  • ETNB 89BIO INC · prev qtr: $19.32M
  • CRGX CARGO THERAPEUTICS INC · prev qtr: $5.00M
  • KMTS KESTRA MED TECHNOLOGIES LTD · prev qtr: $3.32M
  • CBLL CERIBELL INC · prev qtr: $2.81M

Insider Transactions (Form 4)

Latest RTW INVESTMENTS, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-09 Buy Orchestra BioMed Holdings, Inc. 1,200,000 $5.00 SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 1,771 — SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 19,934 — SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 161,807 — SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 209,254 — SEC filing
2026-04-27 Sell Orchestra BioMed Holdings, Inc. 32 $4.13 SEC filing
2026-04-27 Opt exercise Orchestra BioMed Holdings, Inc. 1,250,032 $0.00 SEC filing
2026-04-20 Buy Kailera Therapeutics, Inc. 500,000 $16.00 SEC filing

All insider transactions →

Fund Profile

RTW Investments, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 84 positions worth $11.71B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-78183 (status: Approved), registered 2013-06-13
  • Regulatory AUM (Form ADV): $14.14B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 2 hedge funds
  • Website: rtwfunds.com

Portfolio Structure

  • 84 positions · $11.71B reported value (Q2 2026)
  • Top 10 holdings = 47.7% of reported value
  • Largest position: MDGL (MADRIGAL PHARMACEUTICALS INC) at 9.1%
  • Average position size: $139.44M

Sector Tilt

  • Health Care 99.1%
  • Industrials 0.4%
  • Information Technology 0.4%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 9 new, 24 added, 8 reduced, 13 exited
  • 43 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 83.9%
Technology 0.2%
Other 15.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.99M $914.42M 11.27%
11.27%
Hold
2 673.50K $496.74M 6.12%
6.12%
Hold
3 11.37M $495.51M 6.11%
6.11%
Add
4 7.75M $475.40M 5.86%
5.86%
Hold
5 3.08M $444.21M 5.47%
5.47%
Hold
6 5.76M $382.39M 4.71%
4.71%
Hold
7 2.00M $321.94M 3.97%
3.97%
Reduce
8 5.48M $260.07M 3.20%
3.20%
Hold
9 4.42M $258.29M 3.18%
3.18%
Reduce
10 866.50K $219.50M 2.71%
2.71%
Hold
11 2.82M $214.57M 2.64%
2.64%
Add
12 2.03M $190.68M 2.35%
2.35%
Reduce
13 3.18M $188.84M 2.33%
2.33%
Add
14 490.00K $181.14M 2.23%
2.23%
Reduce
15 4.87M $176.92M 2.18%
2.18%
Hold
16 7.14M $152.46M 1.88%
1.88%
Reduce
17 2.72M $149.55M 1.84%
1.84%
Hold
18 1.06M $149.09M 1.84%
1.84%
Hold
19 1.12M $135.89M 1.67%
1.67%
Reduce
20 5.12M $120.40M 1.48%
1.48%
Hold
21 2.71M $107.75M 1.33%
1.33%
Hold
22 2.59M $106.12M 1.31%
1.31%
Hold
23 683.29K $100.82M 1.24%
1.24%
Hold
24 3.26M $98.01M 1.21%
1.21%
Add
25 1.48M $92.53M 1.14%
1.14%
Add
26 4.54M $90.65M 1.12%
1.12%
Hold
27 202.46K $90.54M 1.12%
1.12%
Hold
28 5.57M $79.64M 0.98%
0.98%
Add
29 24.35M $79.64M 0.98%
0.98%
Reduce
30 2.29M $77.65M 0.96%
0.96%
Reduce
31 8.82M $75.11M 0.93%
0.93%
Add
32 6.22M $72.97M 0.90%
0.90%
Add
33 1.70M $68.52M 0.84%
0.84%
Hold
34 3.30M $65.55M 0.81%
0.81%
Hold
35 3.62M $60.70M 0.75%
0.75%
Hold
36 17.69M $57.66M 0.71%
0.71%
Hold
37 2.29M $55.57M 0.69%
0.69%
Add
38 1.67M $50.17M 0.62%
0.62%
Reduce
39 8.71M $49.89M 0.61%
0.61%
Add
40 3.47M $49.79M 0.61%
0.61%
New
41 5.43M $47.91M 0.59%
0.59%
Add
42 250.00K $47.65M 0.59%
0.59%
Reduce
43 863.39K $40.22M 0.50%
0.50%
Hold
44 1.47M $37.92M 0.47%
0.47%
Hold
45 1.95M $37.41M 0.46%
0.46%
Hold
46 2.89M $36.57M 0.45%
0.45%
Add
47 872.39K $36.33M 0.45%
0.45%
Add
48 6.25M $34.94M 0.43%
0.43%
New
49 350.00K $29.71M 0.37%
0.37%
New
50 393.50K $29.55M 0.36%
0.36%
Reduce

FAQ

What did RTW INVESTMENTS, LP buy in 2025-Q3?

In its 2025-Q3 13F filing, RTW INVESTMENTS, LP reported 74 equity positions worth $8.12B in aggregate; its largest disclosed positions were MDGL ($914.42M), ARGX ($496.74M), RNAM ($495.51M).

How large is RTW INVESTMENTS, LP's portfolio?

RTW INVESTMENTS, LP reported $8.12B of long equity holdings across 74 positions as of 2025-Q3. Top-10 holdings account for 52.6% of reported value.

What is RTW INVESTMENTS, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rtw-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →